Related Experiment Video
Updated: Mar 13, 2026

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
NAFLD and diabetes mellitus
Herbert Tilg1, Alexander R Moschen1, Michael Roden2,3,4
1Department of Internal Medicine I, Gastroenterology, Endocrinology &Metabolism, Medical University Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.
Abstract:
The liver constitutes a key organ in systemic metabolism, contributing substantially to the development of insulin resistance and type 2 diabetes mellitus (T2DM). The mechanisms underlying these processes are not entirely understood, but involve hepatic fat accumulation, alterations of energy metabolism and inflammatory signals derived from various cell types including immune cells. Lipotoxins, mitochondrial function, cytokines and adipocytokines have been proposed to play a major part in both NAFLD and T2DM. Patients with NAFLD are commonly insulin resistant. On the other hand, a large number of patients with T2DM develop NAFLD with its inflammatory complication, NASH. The high incidence of NASH in patients with T2DM leads to further complications, such as liver cirrhosis and hepatocellular carcinoma, which are increasingly recognized. Therapeutic concepts such as thiazolidinediones (glitazones) for treating T2DM also show some efficacy in the treatment of NASH. This Review will describe the multifaceted and complex interactions between the liver and T2DM.
Insights
The liver plays a key role in metabolism, impacting insulin resistance and type 2 diabetes mellitus (T2DM). Understanding liver-T2DM interactions is crucial for developing effective treatments for conditions like non-alcoholic fatty liver disease (NAFLD).
Area of Science:
- Metabolic research
- Hepatology
- Endocrinology
Background:
- The liver is central to systemic metabolism and its dysfunction contributes to insulin resistance and type 2 diabetes mellitus (T2DM).
- Hepatic fat accumulation, altered energy metabolism, and inflammation involving immune cells are key mechanisms.
- Lipotoxins, mitochondrial dysfunction, cytokines, and adipocytokines are implicated in non-alcoholic fatty liver disease (NAFLD) and T2DM.
Purpose of the Study:
- To elucidate the complex interplay between the liver and T2DM.
- To review the mechanisms linking hepatic dysfunction to metabolic disorders.
- To highlight the clinical relevance of NAFLD and its progression in T2DM patients.
Main Methods:
- This review synthesizes current scientific literature.
- It examines the roles of hepatic fat, energy metabolism, and inflammation.
- It discusses the impact of T2DM on liver disease and vice versa.
Main Results:
- Patients with NAFLD frequently exhibit insulin resistance.
- A significant proportion of T2DM patients develop NAFLD, often progressing to non-alcoholic steatohepatitis (NASH).
- NASH in T2DM increases risks for cirrhosis and hepatocellular carcinoma.
Conclusions:
- The liver and T2DM share intricate, bidirectional relationships.
- Therapeutic strategies for T2DM, like thiazolidinediones, may also benefit NASH.
- Further research into these interactions is vital for managing metabolic and liver diseases.
More Related Videos
10:17An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
Published on: April 26, 2019
10:07Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tgfli:EGFP Zebrafish Retinal Vasculature
Published on: December 26, 2017
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Nephrotic Syndrome I : Introduction